TissGeneSummary for NRIP3 |
Gene summary |
Basic gene information | Gene symbol | NRIP3 |
Gene name | nuclear receptor interacting protein 3 | |
Synonyms | C11orf14|NY-SAR-105 | |
Cytomap | UCSC genome browser: 11p15.3 | |
Type of gene | protein-coding | |
RefGenes | NM_020645.2, | |
Description | nuclear receptor-interacting protein 3sarcoma antigen NY-SAR-105 | |
Modification date | 20141207 | |
dbXrefs | MIM : 613125 | |
HGNC : HGNC | ||
Ensembl : ENSG00000175352 | ||
HPRD : 14840 | ||
Vega : OTTHUMG00000165680 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NRIP3 | |
BioGPS: 56675 | ||
Pathway | NCI Pathway Interaction Database: NRIP3 | |
KEGG: NRIP3 | ||
REACTOME: NRIP3 | ||
Pathway Commons: NRIP3 | ||
Context | iHOP: NRIP3 | |
ligand binding site mutation search in PubMed: NRIP3 | ||
UCL Cancer Institute: NRIP3 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of NRIP3 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for NRIP3 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUSC | 2.135026194 | 0.239355606 | 1.895670588 | 1.01E-17 | 8.88E-17 |
KICH | 3.429042586 | 0.229506586 | 3.199536 | 6.68E-08 | 3.16E-07 |
HNSC | 1.539236819 | -0.501607367 | 2.040844186 | 9.67E-12 | 2.53E-10 |
LUAD | 1.645851414 | 0.361160034 | 1.284691379 | 4.52E-07 | 1.57E-06 |
KIRP | -1.128768414 | -0.038559039 | -1.090209375 | 0.00178 | 0.004581814 |
Top |
TissGene-miRNA for NRIP3 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for NRIP3 |
TissGeneSNV for NRIP3 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R202Q | UCEC | 2 |
p.R77Q | COAD | 1 |
p.R66S | BLCA | 1 |
p.K205R | STAD | 1 |
p.P60L | SKCM | 1 |
p.E223D | UCEC | 1 |
p.L196V | LUSC | 1 |
p.Q26H | CHOL | 1 |
p.G79R | LUAD | 1 |
p.R81C | PAAD | 1 |
p.R66M | BLCA | 1 |
p.R160W | STAD | 1 |
p.L131F | LGG | 1 |
p.M107L | SKCM | 1 |
p.P83L | SKCM | 1 |
p.S157Y | STAD | 1 |
p.L198I | LUSC | 1 |
p.D106G | STAD | 1 |
p.V231L | OV | 1 |
p.R66I | BLCA | 1 |
p.S203Y | UCEC | 1 |
p.G98E | SKCM | 1 |
p.S78I | HNSC | 1 |
p.R160Q | STAD | 1 |
p.R67C | READ | 1 |
p.R160W | PAAD | 1 |
p.P83S | SKCM | 1 |
p.S232Y | UCEC | 1 |
p.R66K | ACC | 1 |
Top |
TissGeneCNV for NRIP3 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for NRIP3 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | BI603836 | DPYD-NRIP3 | chr1:98049359 | chr11:9002563 |
Top |
TissGeneNet for NRIP3 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for NRIP3 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for NRIP3 |
TissGeneDrug for NRIP3 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for NRIP3 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |